DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 19, 2014-- Covidien plc (NYSE:COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The...
DUBLIN, Ireland--(BUSINESS WIRE)--Mar. 19, 2014-- Covidien plc (NYSE:COV) today announced that its Board of Directors has declared a quarterly cash dividend of $0.32 per ordinary share. The dividend is payable on May 5, 2014, to shareholders of record on April 7, 2014.
About Covidien
Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien develops, manufactures and sells a diverse range of industry-leading medical device and supply products. With 2013 revenue of $10.2 billion, Covidien has more than 38,000 employees worldwide in more than 70 countries, and its products are sold in over 150 countries. Please visit www.covidien.com to learn more about our business.
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20140319006268r1&sid=acqr7&distro=nx)
Source: Covidien
External Communications
Peter Lucht, 508-452-4168
Vice President
Peter.lucht@covidien.com
or
Investor Relations
Coleman Lannum, CFA, 508-452-4343
Vice President
cole.lannum@covidien.com
or
Corporate Communications
Lisa Clemence, 508-452-4375
Director
lisa.clemence@covidien.com
or
Investor Relations
Todd Carpenter, 508-452-4363
Senior Director
todd.carpenter@covidien.com